Nymox Pharmaceutical Corp.
(NASDAQ : NYMX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
ABTAbbott Laboratories -1.11%105.670.8%$718.79m
TMOThermo Fisher Scientific, Inc. -1.79%421.371.0%$619.04m
MDTMedtronic Plc -3.96%103.340.6%$524.30m
ISRGIntuitive Surgical, Inc. -1.77%643.952.4%$431.80m
DHRDanaher Corp. -1.16%203.910.7%$407.57m
BDXBecton, Dickinson & Co. -1.80%227.731.0%$398.15m
INOInovio Pharmaceuticals, Inc. 4.97%17.845.9%$394.57m
QDELQuidel Corp. 4.92%198.627.7%$387.95m
DXCMDexCom, Inc. 0.08%389.647.9%$303.06m
BSXBoston Scientific Corp. -1.00%38.101.0%$272.57m
SYKStryker Corp. -2.16%201.931.3%$271.88m
VARVarian Medical Systems, Inc. -0.22%172.499.1%$271.62m
BAXBaxter International, Inc. -3.54%80.031.8%$243.06m
ALGNAlign Technology, Inc. -1.65%315.666.4%$223.34m
EWEdwards Lifesciences Corp. -3.28%80.470.4%$212.92m

Company Profile

Nymox Pharmaceutical Corp. operates as a biopharmaceutical company, which engages in the research and development on products for the aging population. Its products include NicAlert and TobacAlert, and the NX-1207 for the treatment of low-grade localized prostate cancer. It operates through the following geographical segments: Canada, United States, and Europe. The company was founded by Paul Averback on May 30, 1995 and is headquartered in Nassau, the Bahamas.